Newsletter | October 22, 2025

10.22.25 -- What Changes To FDA And CBER Mean For The Future Of CGT With Daniela Drago

SPONSOR

Webinar: Streamlining Biotherapy QC: Practical Solutions for Protein Analytics & Residual DNA Testing

Biologic therapies are transforming healthcare—but complex QC challenges can slow progress. Join this Thermo Fisher Scientific webinar to uncover common pitfalls in HPLC protein analytics and residual DNA testing, debunk persistent myths, and gain practical strategies to enhance robustness and reproducibility. Learn how proactive QC planning can streamline workflows and accelerate biotherapeutic development. Click here to learn more.

FOCUS ON REGULATORY & COMPLIANCE

What Changes To FDA And CBER Mean For The Future Of CGT With Daniela Drago

This is Episode 4 of "FDA Fridays," a special series from Cell & Gene: The Podcast, Chief Editor Erin Harris speaks with regulatory affairs expert Daniela Drago, Partner, NDA Partners, about how shifting FDA and CBER priorities under the current administration could influence the trajectory of cell and gene therapy development.

Can Your Facility Cleaning And Disinfection Withstand Regulatory Review?

Explore facility cleaning, monitoring, and disinfection strategies to meet regulatory standards, emphasizing planning, stakeholder involvement, testing, trending, documentation, and continuous improvement.

Navigating GMP Certification In Cell And Gene Therapy Manufacturing

CGT regulations are rapidly evolving. With hundreds of therapies in development, scalable automation and smarter systems are essential to meet compliance, reduce complexity, and protect patient lives.

How To Build Flexibility Into Your CGT Manufacturing Process

Scaling production demands both flexibility and strict compliance. See how innovators can rethink strategies and streamline processes to meet demand without compromising patient safety or regulatory standards.

What Your Environmental Monitoring Isn't Telling You

View often overlooked contamination sources, like residues, poor housekeeping, and training gaps, which offer practical, actionable strategies to strengthen and optimize your contamination control program.

Recommendations For Successful IND Approval Of RNA-LNP Drugs

The existing regulatory system is ambiguous for RNA therapeutics. Leverage this Investigational New Drug (IND) guide to help accelerate and strengthen the process IND filing of novel nanomedicines.

Using Spectroscopy For Automated Monitoring Of A Cell Culture Bioprocess

Discover how Raman spectroscopy and parallel bioprocessing enable real-time cell culture monitoring, saving time and providing crucial data for process optimization in biopharmaceutical production.

5 Ways To Drive Lab Sustainability

Laboratories drive innovation, but their environmental impact is growing. Learn five practical tips to make your lab more sustainable to reduce waste, and support global climate goals.

Impact Of Contamination Control Strategy On Cleaning And Disinfection

New EU rules tighten grip on contamination control for sterile drugs. Ensure your cleaning and disinfection meet the stricter standards to proactively identify, evaluate, and control contamination risks.

The Hidden Cost Of Off-The-Shelf Media In Cell Therapy

Generic, off-the-shelf media can introduce hidden costs and delays in cell and gene therapy development. A strategic media approach is a critical advantage that can accelerate your path to the clinic.

Understanding FDA Calibration Requirements For Reducing Risks

Become fully equipped with the essential tools and strategies needed to strengthen your calibration efforts and better position your organization for success in regulatory audits.

Recombinant Trypsin Frequently Asked Questions

Assimilate more about the key features of a high-quality recombinant trypsin and how it can benefit your bioprocess with insightful answers to these common questions.

SPONSOR

Join life sciences experts and global regulators this 9–10 December for the 2025 ISPE Pharma 4.0™ Conference in Barcelona, Spain, or virtually. This year's agenda spotlights how innovative enabling technologies including AI, machine learning, virtual and augmented reality, industrial internet of things, GxP cloud platforms, robotics, advanced modeling, and automation, are addressing key challenges like drug shortages and improving product availability.

REGULATORY & COMPLIANCE SOLUTIONS

Accelerate Innovation With Compliant Software Solutions - MasterControl, Inc.

A Tool For Rapid Quantification Of Nanoparticles - Corning Life Sciences

Partner With The Experts In Annex 1 - Ecolab Life Sciences

EVENTS

Advancing the Future of Cell & Gene Therapy

This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines.

 

Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now

Connect With Cell & Gene: